Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium
- PMID: 21681796
- PMCID: PMC3122147
- DOI: 10.1002/ana.22403
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium
Abstract
Objective: White matter hyperintensities (WMHs) detectable by magnetic resonance imaging are part of the spectrum of vascular injury associated with aging of the brain and are thought to reflect ischemic damage to the small deep cerebral vessels. WMHs are associated with an increased risk of cognitive and motor dysfunction, dementia, depression, and stroke. Despite a significant heritability, few genetic loci influencing WMH burden have been identified.
Methods: We performed a meta-analysis of genome-wide association studies (GWASs) for WMH burden in 9,361 stroke-free individuals of European descent from 7 community-based cohorts. Significant findings were tested for replication in 3,024 individuals from 2 additional cohorts.
Results: We identified 6 novel risk-associated single nucleotide polymorphisms (SNPs) in 1 locus on chromosome 17q25 encompassing 6 known genes including WBP2, TRIM65, TRIM47, MRPL38, FBF1, and ACOX1. The most significant association was for rs3744028 (p(discovery) = 4.0 × 10(-9) ; p(replication) = 1.3 × 10(-7) ; p(combined) = 4.0 × 10(-15) ). Other SNPs in this region also reaching genome-wide significance were rs9894383 (p = 5.3 × 10(-9) ), rs11869977 (p = 5.7 × 10(-9) ), rs936393 (p = 6.8 × 10(-9) ), rs3744017 (p = 7.3 × 10(-9) ), and rs1055129 (p = 4.1 × 10(-8) ). Variant alleles at these loci conferred a small increase in WMH burden (4-8% of the overall mean WMH burden in the sample).
Interpretation: This large GWAS of WMH burden in community-based cohorts of individuals of European descent identifies a novel locus on chromosome 17. Further characterization of this locus may provide novel insights into the pathogenesis of cerebral WMH.
Copyright © 2011 American Neurological Association.
Figures


Comment in
-
Uncovering the genetic architecture of white matter disease.Ann Neurol. 2011 Jun;69(6):907-8. doi: 10.1002/ana.22460. Ann Neurol. 2011. PMID: 21681793 No abstract available.
References
-
- Longstreth WT., Jr Brain vascular disease overt and covert. Stroke. 2005;36:2062–2063. - PubMed
-
- Launer LJ. Epidemiology of white matter lesions. Top Magn Reson Imaging. 2004;15:365–367. - PubMed
-
- Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke. 1997;28:652–659. - PubMed
-
- Atwood LD, Wolf PA, Heard-Costa NL, et al. Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke. 2004;35:1609–1613. - PubMed
-
- Carmelli D, DeCarli C, Swan GE, et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke. 1998;29:1177–1181. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01 HC055016/HL/NHLBI NIH HHS/United States
- R01 NS017950/NS/NINDS NIH HHS/United States
- R01 AG016495/AG/NIA NIH HHS/United States
- N01 HC055020/HL/NHLBI NIH HHS/United States
- DK063491/DK/NIDDK NIH HHS/United States
- N01 HC045133/HC/NHLBI NIH HHS/United States
- N01 HC035129/HC/NHLBI NIH HHS/United States
- R01 AG031287/AG/NIA NIH HHS/United States
- UL1RR025005/RR/NCRR NIH HHS/United States
- U01-HG004402/HG/NHGRI NIH HHS/United States
- N01-HC-25195/HC/NHLBI NIH HHS/United States
- N01 AG012100/AG/NIA NIH HHS/United States
- N01 HC055019/HL/NHLBI NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- U01 HL080295/HL/NHLBI NIH HHS/United States
- N01-HC-55022/HC/NHLBI NIH HHS/United States
- N01 HC055021/HL/NHLBI NIH HHS/United States
- N01 HC015103/HC/NHLBI NIH HHS/United States
- N01 HC085086/HL/NHLBI NIH HHS/United States
- N01-HC-55016/HC/NHLBI NIH HHS/United States
- N01 HC055015/HL/NHLBI NIH HHS/United States
- AG033193/AG/NIA NIH HHS/United States
- R01 HL087652/HL/NHLBI NIH HHS/United States
- R01 AG040282/AG/NIA NIH HHS/United States
- N01-HC-55021/HC/NHLBI NIH HHS/United States
- HHSN268200625226C/PHS HHS/United States
- U01 HG004402/HG/NHGRI NIH HHS/United States
- N01-HC-85086/HC/NHLBI NIH HHS/United States
- R01-HL087641/HL/NHLBI NIH HHS/United States
- R01 HL093029/HL/NHLBI NIH HHS/United States
- NS17950/NS/NINDS NIH HHS/United States
- R01-HL087652/HL/NHLBI NIH HHS/United States
- P 20545/FWF_/Austrian Science Fund FWF/Austria
- AG08122/AG/NIA NIH HHS/United States
- P30 DK063491/DK/NIDDK NIH HHS/United States
- R01 AG008122/AG/NIA NIH HHS/United States
- N01-HC-55019/HC/NHLBI NIH HHS/United States
- M01RR00425/RR/NCRR NIH HHS/United States
- N01 HC025195/HL/NHLBI NIH HHS/United States
- R01 AG033193/AG/NIA NIH HHS/United States
- N01-HC-55015/HC/NHLBI NIH HHS/United States
- N01 HC055222/HL/NHLBI NIH HHS/United States
- N01-HC-55222/HC/NHLBI NIH HHS/United States
- R01-HL093029/HL/NHLBI NIH HHS/United States
- N01 HC085079/HL/NHLBI NIH HHS/United States
- N01-HC-75150/HC/NHLBI NIH HHS/United States
- N01-HC-55020/HC/NHLBI NIH HHS/United States
- AG031287/AG/NIA NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- N01 HC055018/HL/NHLBI NIH HHS/United States
- M01 RR000425/RR/NCRR NIH HHS/United States
- AG16495/AG/NIA NIH HHS/United States
- N01-HC-85079/HC/NHLBI NIH HHS/United States
- N01 HC055022/HL/NHLBI NIH HHS/United States
- K23 AG038444/AG/NIA NIH HHS/United States
- P30 AG010129/AG/NIA NIH HHS/United States
- N01 HC075150/HL/NHLBI NIH HHS/United States
- N01-HC-55018/HC/NHLBI NIH HHS/United States
- R01 HL087641/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources